These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23436807)
41. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance. Sousa AM; Monteiro R; Pereira MO Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031 [TBL] [Abstract][Full Text] [Related]
42. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients. Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530 [TBL] [Abstract][Full Text] [Related]
43. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Field TR; White A; Elborn JS; Tunney MM Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934 [TBL] [Abstract][Full Text] [Related]
44. Biofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas aeruginosa. Perez LR; Barth AL Braz J Infect Dis; 2011; 15(4):301-4. PubMed ID: 21860998 [TBL] [Abstract][Full Text] [Related]
45. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents. Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T Chemotherapy; 1997; 43(2):137-41. PubMed ID: 9084923 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of Artesunate against Bao L; Guo J; Feng L; Zhou X; Lu Q Biomed Res Int; 2019; 2019():4810217. PubMed ID: 31815139 [No Abstract] [Full Text] [Related]
47. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Banin E; Brady KM; Greenberg EP Appl Environ Microbiol; 2006 Mar; 72(3):2064-9. PubMed ID: 16517655 [TBL] [Abstract][Full Text] [Related]
48. Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill Sweeney E; Sabnis A; Edwards AM; Harrison F Microbiology (Reading); 2020 Dec; 166(12):1171-1180. PubMed ID: 33253080 [No Abstract] [Full Text] [Related]
49. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300 [TBL] [Abstract][Full Text] [Related]
50. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. Alhede M; Kragh KN; Qvortrup K; Allesen-Holm M; van Gennip M; Christensen LD; Jensen PØ; Nielsen AK; Parsek M; Wozniak D; Molin S; Tolker-Nielsen T; Høiby N; Givskov M; Bjarnsholt T PLoS One; 2011; 6(11):e27943. PubMed ID: 22132176 [TBL] [Abstract][Full Text] [Related]
51. Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung. Miller JK; Brantner JS; Clemons C; Kreider KL; Milsted A; Wilber P; Yun YH; Youngs WJ; Young G; Badawy HT; Milsted A; Clemons C; Kreider KL; Wilber P; Young G; Yun YH; Wagers PO; Youngs WJ Math Med Biol; 2014 Jun; 31(2):179-204. PubMed ID: 23518337 [TBL] [Abstract][Full Text] [Related]
52. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis. Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742 [TBL] [Abstract][Full Text] [Related]
53. Intragenic Antimicrobial Peptide Hs02 Hampers the Proliferation of Single- and Dual-Species Biofilms of Bessa LJ; Manickchand JR; Eaton P; Leite JRSA; Brand GD; Gameiro P Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340580 [No Abstract] [Full Text] [Related]
54. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa. Soren O; Rineh A; Silva DG; Cai Y; Howlin RP; Allan RN; Feelisch M; Davies JC; Connett GJ; Faust SN; Kelso MJ; Webb JS J Antimicrob Chemother; 2020 Jan; 75(1):117-125. PubMed ID: 31682251 [TBL] [Abstract][Full Text] [Related]
55. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272 [TBL] [Abstract][Full Text] [Related]